Literature DB >> 6170243

Bleomycin-induced pulmonary fibrosis. Effects of steroid on lung collagen metabolism.

S H Phan, R S Thrall, C Williams.   

Abstract

Using bleomycin-induced pulmonary fibrosis as a model, we have set out to study collagen metabolism in the fibrotic process. As was previously shown, intratracheal administration of bleomycin in the rat caused increased deposition and net synthesis of collagen in the lung. This was accompanied by marked increases in the tissue-free proline pool size and less dramatic increases in the pool's radioactivity when lung mince was pulsed with radioactive proline to measure the net collagen synthesis. Using a technique based on the quantitation of the rate of release of hydroxyproline-containing peptides when lung homogenates were incubated in calcium-containing buffer, lung collagenolytic activity was markedly diminished as a result of bleomycin treatment. Concomitant treatment with the steroid methylprednisolone did not affect significantly this decrease in lung collagenolytic activity. Such steroid treatment, however, prevented the increase in bleomycin-induced lung collagen deposition and partially suppressed total lung collagen synthesis, without affecting the net rate of lung collagen synthesis expressed per mg of DNA. Steroid treatment also inhibited the marked increase in tissue-free proline pool size and radioactivity caused by bleomycin. The mechanism of amelioration of the fibrotic response by the steroid is discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170243     DOI: 10.1164/arrd.1981.124.4.428

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  32 in total

1.  Stimulation of rat endothelial cell transforming growth factor-beta production by bleomycin.

Authors:  S H Phan; M Gharaee-Kermani; F Wolber; U S Ryan
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

2.  Beyond TGF-beta: a prostaglandin promotes fibrosis.

Authors:  Mitchell A Olman
Journal:  Nat Med       Date:  2009-12       Impact factor: 53.440

3.  Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.

Authors:  J G Hay; P L Haslam; A Dewar; B Addis; M Turner-Warwick; G J Laurent
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

4.  Progress of bleomycin-induced lung fibrosis in rabbits.

Authors:  C M O'Connor; A O'Brien; E C Sweeney; M X FitzGerald
Journal:  Br J Exp Pathol       Date:  1986-08

5.  Inhibition of bleomycin-induced pulmonary fibrosis by nordihydroguaiaretic acid. The role of alveolar macrophage activation and mediator production.

Authors:  S H Phan; S L Kunkel
Journal:  Am J Pathol       Date:  1986-08       Impact factor: 4.307

6.  Coordinate regulation of transforming growth factor beta gene expression and cell proliferation in hamster lungs undergoing bleomycin-induced pulmonary fibrosis.

Authors:  B Raghow; P Irish; A H Kang
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

7.  Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence.

Authors:  S N Giri; D M Hyde
Journal:  Am J Pathol       Date:  1988-12       Impact factor: 4.307

8.  Collagen breakdown products and lung collagen metabolism: an in vitro study on fibroblast cultures.

Authors:  C Gardi; P Calzoni; P Marcolongo; E Cavarra; L Vanni; G Lungarella
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

9.  Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice.

Authors:  David M Habiel; Milena S Espindola; Ana L Coelho; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2018-02-17       Impact factor: 4.307

10.  Respiratory reovirus 1/L induction of intraluminal fibrosis, a model of bronchiolitis obliterans organizing pneumonia, is dependent on T lymphocytes.

Authors:  Elizabeth I Majeski; Manjeet K Paintlia; Andrea D Lopez; Russell A Harley; Steven D London; Lucille London
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.